HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boecker, H. Articles by Spilker, M. E. Search for Related Content PubMed PubMed Citation Articles by Boecker, H. Articles by Spilker, M. E.

Optimal Duration of PET Studies with ¹⁸F-Fluoroethyl-Diprenorphine

¹ Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
² Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

The tracer 6-O-(2-¹⁸F-fluoroethyl)-6-O-desmethyldiprenorphine (¹⁸F-FDPN) provides enhanced flexibility to PET studies of the opioidergic system because the label has a longer half-life than the label of ¹¹C-diprenorphine. Here we evaluated the ideal length of PET studies with ¹⁸F-FDPN. Methods: ¹⁸F-FDPN binding kinetics were quantified with protocols of different lengths by use of a 1-tissue or a 2-tissue compartment model for different volumes of interest. Furthermore, the effects of scanning duration were assessed by parametric analyses. Results: A 90-min protocol resulted in less than 10% bias in distribution volume (DV) relative to the full-length protocol. Correlation analyses of the DV estimates for the full-length protocol and the shortened protocols showed good replication of DV estimates for regions with both low and high levels of binding at schedules of up to 90 min. Conclusion: Data sampling in dynamic ¹⁸F-FDPN PET acquisitions should not be shorter than 90 min to maintain reliable estimates of DV.

Key Words: ¹⁸F-fluoroethyl-diprenorphine • PET • protocol optimization • ligand analysis

Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 7a-8a. [Full Text]  

This article has been cited by other articles:

				H. Boecker, T. Sprenger, M. E. Spilker, G. Henriksen, M. Koppenhoefer, K. J. Wagner, M. Valet, A. Berthele, and T. R. Tolle The Runner's High: Opioidergic Mechanisms in the Human Brain Cereb Cortex, November 1, 2008; 18(11): 2523 - 2531. [Abstract] [Full Text] [PDF]